A recent study highlights Tofacitinib's, a drug used to treat rheimatoid arthritis, promising results in treating baldness. Tofacitinib monotherapy showed a 23.5% hair regrowth in eight months, maintaining with 5mg alternate-day dosage. However, efficacy dimi…